Olema Pharmaceuticals, Inc. (OLMA) Documents: SEC Filings, Investor Presentations & Press Releases

Olema Pharmaceuticals, Inc. (OLMA) documents, SEC filings and the IR site together: 96 documents, newest first; latest 2026-08-13. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site

Date	Type	Document
2026-08-13	8-K	Form 8-K, Item 5.02
2026-08-10	8-K	Form 8-K, Item 2.02 results
2026-08-10	10-Q	Form 10-Q for the quarter ended Jun 30
2026-08-01	Deck	Olema Corporate Presentation – August 2026
2026-06-23	8-K	Form 8-K, Item 5.07
2026-05-26	8-K	Form 8-K, Item 7.01
2026-05-21	8-K	Form 8-K, Item 7.01
2026-05-12	Press release	Olema Oncology Reports First Quarter 2026 Financial and Operating Results
2026-05-12	8-K	Form 8-K, Item 2.02 results
2026-05-12	10-Q	Form 10-Q for the quarter ended Mar 31
2026-05-01	8-K	Form 8-K, Item 1.01
2026-04-29	8-K	Form 8-K, Item 5.02
2026-04-29	Proxy	Definitive proxy statement
2026-03-16	Press release	Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
2026-03-16	8-K	Form 8-K, Item 2.02 results
2026-03-16	10-K	Annual report on Form 10-K, FY25
2026-01-30	8-K	Form 8-K, Item 5.02
2026-01-12	8-K	Form 8-K, Item 2.02 results
2025-11-19	8-K	Form 8-K, Item 8.01
2025-11-18	8-K	Form 8-K, Item 8.01
2025-11-10	Press release	Olema Oncology Reports Third Quarter 2025 Financial and Operating Results
2025-11-10	8-K	Form 8-K, Item 2.02 results
2025-11-10	10-Q	Form 10-Q for the quarter ended Sep 30
2025-10-20	8-K	Form 8-K, Item 7.01
2025-09-02	8-K	Form 8-K, Item 7.01
2025-08-11	Press release	Olema Oncology Reports Second Quarter 2025 Financial and Operating Results
2025-08-11	8-K	Form 8-K, Item 2.02 results
2025-08-11	10-Q	Form 10-Q for the quarter ended Jun 30
2025-06-13	8-K	Form 8-K, Item 5.07
2025-05-13	Press release	Olema Oncology Reports First Quarter 2025 Financial and Operating Results
2025-05-13	8-K	Form 8-K, Item 2.02 results
2025-05-13	10-Q	Form 10-Q for the quarter ended Mar 31
2025-04-28	Proxy	Definitive proxy statement
2025-03-18	Press release	Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results
2025-03-18	8-K	Form 8-K, Item 2.02 results
2025-03-18	10-K	Annual report on Form 10-K, FY24
2025-03-05	8-K	Form 8-K, Item 7.01
2025-01-13	8-K	Form 8-K, Item 7.01
2025-01-10	8-K	Form 8-K, Item 3.02
2024-12-10	8-K	Form 8-K, Item 7.01

OLMA overview · OLMA earnings · OLMA financials · OLMA KPIs · OLMA ownership · OLMA peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.